Other News To Note
Tuesday, October 22, 2013
• Anacor Pharmaceuticals Inc., of Palo Alto, Calif., signed a research agreement with the U.S. Department of Defense, Defense Threat Reduction Agency for design of new classes of systemic antibiotics.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.